» Articles » PMID: 39551788

Fueling Neurodegeneration: Metabolic Insights into Microglia Functions

Overview
Publisher Biomed Central
Date 2024 Nov 17
PMID 39551788
Authors
Affiliations
Soon will be listed here.
Abstract

Microglia, the resident immune cells of the central nervous system, emerge in the brain during early embryonic development and persist throughout life. They play essential roles in brain homeostasis, and their dysfunction contributes to neuroinflammation and the progression of neurodegenerative diseases. Recent studies have uncovered an intricate relationship between microglia functions and metabolic processes, offering fresh perspectives on disease mechanisms and possible treatments. Despite these advancements, there are still significant gaps in our understanding of how metabolic dysregulation affects microglial phenotypes in these disorders. This review aims to address these gaps, laying the groundwork for future research on the topic. We specifically examine how metabolic shifts in microglia, such as the transition from oxidative phosphorylation and mitochondrial metabolism to heightened glycolysis during proinflammatory states, impact the disease progression in Alzheimer's disease, multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. Additionally, we explore the role of iron, fatty and amino acid metabolism in microglial homeostasis and repair. Identifying both distinct and shared metabolic adaptations in microglia across neurodegenerative diseases could reveal common therapeutic targets and provide a deeper understanding of disease-specific mechanisms underlying multiple CNS disorders.

Citing Articles

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer's Disease Therapeutics.

Dias D, Socodato R Biomedicines. 2025; 13(2).

PMID: 40002692 PMC: 11852436. DOI: 10.3390/biomedicines13020279.


Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.

Rojas-Pirela M, Andrade-Alviarez D, Rojas V, Marcos M, Salete-Granado D, Chacon-Arnaude M Open Biol. 2025; 15(2):240239.

PMID: 39904372 PMC: 11793985. DOI: 10.1098/rsob.240239.


Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders.

Kim M, Lee J Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852123 PMC: 11763386. DOI: 10.3390/cimb47010008.


SENP1 inhibits aerobic glycolysis in Aβ-incubated astrocytes by promoting PUM2 deSUMOylation.

Liu Q, Jiang M, Wang Z, Meng J, Jia H, Li J Cell Biol Toxicol. 2025; 41(1):28.

PMID: 39794619 PMC: 11723902. DOI: 10.1007/s10565-025-09986-6.

References
1.
Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A . Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One. 2013; 8(3):e57573. PMC: 3597727. DOI: 10.1371/journal.pone.0057573. View

2.
Machado-Santos J, Saji E, Troscher A, Paunovic M, Liblau R, Gabriely G . The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018; 141(7):2066-2082. PMC: 6022681. DOI: 10.1093/brain/awy151. View

3.
Danzer K, Kranich L, Ruf W, Cagsal-Getkin O, Winslow A, Zhu L . Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012; 7:42. PMC: 3483256. DOI: 10.1186/1750-1326-7-42. View

4.
McComb M, Browne R, Bhattacharya S, Bodziak M, Jakimovski D, Weinstock-Guttman B . The cholesterol autoxidation products, 7-ketocholesterol and 7β-hydroxycholesterol are associated with serum neurofilaments in multiple sclerosis. Mult Scler Relat Disord. 2021; 50:102864. DOI: 10.1016/j.msard.2021.102864. View

5.
Ramanan S, Kooshki M, Zhao W, Hsu F, Riddle D, Robbins M . The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. Int J Radiat Oncol Biol Phys. 2009; 75(3):870-7. PMC: 2789462. DOI: 10.1016/j.ijrobp.2009.06.059. View